Search Results - Sam Saibil
- Showing 1 - 3 results of 3
-
1
738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors by Daniel J Olson, Ecaterina Dumbrava, Benjamin Schlechter, Maria Apostolopoulou, Kara Moss, Deyaa Adib, Sam Saibil, Martin Gutierez, Syma Iqbal, Davendra Sohal
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
2
654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors by Marcus Butler, Daniel J Olson, Antonio Giordano, Ecaterina Dumbrava, Benjamin Schlechter, Maria Apostolopoulou, Mridula George, Brooke Pieke, Kara Moss, Deyaa Adib, Sam Saibil, Miriam Gavriliuc, Emily Lichtenstein, Jill Geisberger, D’Arcy Kirkwood, Salina Dang
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
3
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT) by Sofia Genta, Katherine Lajkosz, Noelle R. Yee, Pavlina Spiliopoulou, Alya Heirali, Aaron R. Hansen, Lillian L. Siu, Sam Saibil, Lee-Anne Stayner, Maryia Yanekina, Maxwell B. Sauder, Sareh Keshavarzi, Abdulazeez Salawu, Olga Vornicova, Marcus O. Butler, Philippe L. Bedard, Albiruni R. Abdul Razak, Robert Rottapel, Andrzej Chruscinski, Bryan Coburn, Anna Spreafico
Published in Journal of Experimental & Clinical Cancer Research (2023-10-01)Get full text
Article